Breaking newsEAN NewsCOVID-19Research
COVID-19 impact on consecutive neurological patients admitted to the emergency department
COVID-19 impact on consecutive neurological patients admitted to the emergency department
The annual societal cost of Parkinson's disease across Europe reached €22.8 billion in 2019 according to a new study within the EAN-led Cost of Illness in Neurology in Europe (COIN-Eu) initiative.
Latest Posts
-
-
Considerations for diagnostic COVID-19 tests -
Breaking newsEAN NewsCOVID-19ResearchDisease burden and clinical severity of the first pandemic wave of COVID-19 in Wuhan, China
Disease burden and clinical severity of the first pandemic wave of COVID-19 in Wuhan, China -
Virology, transmission, and pathogenesis of SARS-CoV-2
-
Breaking newsEAN NewsCOVID-19ResearchConvalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)
Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial) -
This year’s Annual Pain Forum was organised online due to the COVID-19 pandemic. -
Breaking newsEAN NewsCOVID-19Research
Neuropathology of patients with COVID-19 in Germany: a post-mortem case series
Neuropathology of patients with COVID-19 in Germany: a post-mortem case series -
Breaking newsEAN NewsCOVID-19Research
Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial -
Breaking newsEAN NewsCOVID-19Research
Prevalence, management, and outcomes of SARS-CoV-2 infections in older people and those with dementia in mental health wards in London, UK: a retrospective observational study
Prevalence, management, and outcomes of SARS-CoV-2 infections in older people and those with dementia in mental health wards in London, UK: a retrospective observational study -
Breaking newsEAN NewsCOVID-19Research
Genomic evidence for reinfection with SARS-CoV-2: a case study
Genomic evidence for reinfection with SARS-CoV-2: a case study -
Remdesivir for the Treatment of Covid-19 — Final Report -
Breaking newsEAN NewsCOVID-19Research
Efficacy of Tocilizumab in Patients Hospitalized with COVID-19
Efficacy of Tocilizumab in Patients Hospitalized with COVID-19 -
Breaking newsEAN NewsCOVID-19Research
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia A Randomized Clinical Trial
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia A Randomized Clinical Trial -
Breaking newsEAN NewsCOVID-19ResearchAssociation Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19
Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19 -
Breaking newsEAN NewsCOVID-19Research
Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia A Randomized Clinical Trial
Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia A Randomized Clinical Trial